Judge Grants Paddock Summary Judgment In Univasc Spat

Law360, New York (October 24, 2006, 12:00 AM EDT) -- A federal court judge has ruled that Paddock Laboratories Inc.’s generic equivalent of the anti-hypertensive drug Univasc does not infringe a patent owned by Warner-Lambert Co.

Schwarz Pharma Inc., Schwarz Pharma AG and Warner-Lambert Co. LLC filed the lawsuit suit in the U.S. District Court for the District of Minnesota in April 2005, alleging that Paddock’s moexipril hydrochloride tablets infringed on their patents.

Judge Ann D. Montgomery, however, granted summary judgment in favor of Paddock.

Warner-Lambert owns the patent, and granted Schwarz Pharma AG an exclusive...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.